These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9316629)
1. Infusional chemotherapy for non-Hodgkin's lymphoma. Molldrem J; Wilson WH Cancer Invest; 1997; 15(5):465-74. PubMed ID: 9316629 [No Abstract] [Full Text] [Related]
2. Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapy. Sparano JA; Wiernik PH; Leaf A; Dutcher JP J Clin Oncol; 1993 Jun; 11(6):1071-9. PubMed ID: 8501493 [TBL] [Abstract][Full Text] [Related]
3. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges. Lokich JJ; Moore CL; Anderson NR Cancer; 1996 Jul; 78(2):294-9. PubMed ID: 8674006 [TBL] [Abstract][Full Text] [Related]
4. Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphoma. Sparano JA; Negassa A; Lansigan E; Locke R; De Silva CR; Wiernik PH Med Oncol; 2005; 22(3):257-67. PubMed ID: 16110137 [TBL] [Abstract][Full Text] [Related]
5. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Laport GF; Williams SF Semin Oncol; 1998 Aug; 25(4):503-17. PubMed ID: 9728600 [TBL] [Abstract][Full Text] [Related]
6. Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen. Sparano JA; Wiernik PH; Strack M; Leaf A; Becker NH; Sarta C; Carney D; Elkind R; Shah M; Valentine ES Leuk Lymphoma; 1994 Jul; 14(3-4):263-71. PubMed ID: 7950915 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it? Dodwell DJ; de Campos ES; Radford JA Drugs; 1992 Jul; 44(1):1-8. PubMed ID: 1379906 [No Abstract] [Full Text] [Related]
8. High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma. Wang WS; Tzeng CH; Chiou TJ; Liu JH; Hsieh RK; Yen CC; Chen PM Jpn J Clin Oncol; 1997 Jun; 27(3):154-7. PubMed ID: 9255269 [TBL] [Abstract][Full Text] [Related]
9. Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone). Zwick C; Birkmann J; Peter N; Bodenstein H; Fuchs R; Hänel M; Reiser M; Hensel M; Clemens M; Zeynalova S; Ziepert M; Pfreundschuh M; Ann Hematol; 2008 Sep; 87(9):717-26. PubMed ID: 18587579 [TBL] [Abstract][Full Text] [Related]
10. The treatment of patients with aggressive non-Hodgkin's lymphoma. Armitage JO Oncology (Williston Park); 2005 Apr; 19(4 Suppl 1):3-6. PubMed ID: 15934512 [No Abstract] [Full Text] [Related]
11. Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: a Southwest Oncology Group Study. Gaynor ER; Unger JM; Miller TP; Grogan TM; White LA; Mills GM; Balcerzak SP; Varterasian M; LeBlanc M; Fisher RI J Clin Oncol; 2001 Feb; 19(3):750-5. PubMed ID: 11157027 [TBL] [Abstract][Full Text] [Related]
12. The evidence-based treatment of AIDS-related non-Hodgkin's lymphoma. Stebbing J; Marvin V; Bower M Cancer Treat Rev; 2004 May; 30(3):249-53. PubMed ID: 15059648 [TBL] [Abstract][Full Text] [Related]
13. [A combination chemotherapy of mitoxantrone, etoposide, carboplatin, and prednisolone (MECP) in recurrent or refractory non-Hodgkin's lymphomas]. Matsuura Y; Nakamura H; Kogure K; Fukazawa M; Okuyama Y; Kawano E; Ishii A; Nishimura M; Hashimoto S; Oh H Gan To Kagaku Ryoho; 1994 Feb; 21(2):237-41. PubMed ID: 8311495 [TBL] [Abstract][Full Text] [Related]
14. Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphoma. Carrión JR; García Arroyo FR; Salinas P Am J Clin Oncol; 1995 Feb; 18(1):44-6. PubMed ID: 7847258 [TBL] [Abstract][Full Text] [Related]
15. [New antitumor drugs for non-Hodgkin's lymphoma]. Ohnishi K; Ohno R Gan To Kagaku Ryoho; 1998 Dec; 25(14):2223-8. PubMed ID: 9881079 [TBL] [Abstract][Full Text] [Related]
16. Weekly mitoxantrone therapy of Hodgkin's disease, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia. A Southeastern Cancer Study Group Trial. Keller JW; Omura GA; Gams RA; Bartolucci AA Am J Clin Oncol; 1987 Jun; 10(3):194-5. PubMed ID: 3591737 [TBL] [Abstract][Full Text] [Related]
17. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma]. Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532 [No Abstract] [Full Text] [Related]
18. Aggressive non-Hodgkin's lymphoma in the elderly: an effective, well-tolerated treatment regimen containing extended-schedule etoposide. Young WA; Greco FA; Greer JP; Hainsworth JD J Natl Cancer Inst; 1994 Sep; 86(17):1346-7. PubMed ID: 8064894 [No Abstract] [Full Text] [Related]